282 related articles for article (PubMed ID: 29924908)
1. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
[TBL] [Abstract][Full Text] [Related]
2. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.
Rajendran P; Kidane AI; Yu TW; Dashwood WM; Bisson WH; Löhr CV; Ho E; Williams DE; Dashwood RH
Epigenetics; 2013 Jun; 8(6):612-23. PubMed ID: 23770684
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
[TBL] [Abstract][Full Text] [Related]
4. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
Abbaoui B; Telu KH; Lucas CR; Thomas-Ahner JM; Schwartz SJ; Clinton SK; Freitas MA; Mortazavi A
J Proteomics; 2017 Mar; 156():94-103. PubMed ID: 28132875
[TBL] [Abstract][Full Text] [Related]
5. Association between histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human colorectal cancer cells.
Hossain S; Liu Z; Wood RJ
J Sci Food Agric; 2021 Mar; 101(5):1833-1843. PubMed ID: 32964464
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W
Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
8. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Martin SL; Kala R; Tollefsbol TO
Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
12. Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity.
Stimson L; Rowlands MG; Newbatt YM; Smith NF; Raynaud FI; Rogers P; Bavetsias V; Gorsuch S; Jarman M; Bannister A; Kouzarides T; McDonald E; Workman P; Aherne GW
Mol Cancer Ther; 2005 Oct; 4(10):1521-32. PubMed ID: 16227401
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells.
Dos Santos PWDS; Machado ART; De Grandis RA; Ribeiro DL; Tuttis K; Morselli M; Aissa AF; Pellegrini M; Antunes LMG
Food Chem Toxicol; 2020 Feb; 136():111047. PubMed ID: 31838189
[TBL] [Abstract][Full Text] [Related]
14. Regulation of histone acetyltransferase TIP60 function by histone deacetylase 3.
Yi J; Huang X; Yang Y; Zhu WG; Gu W; Luo J
J Biol Chem; 2014 Dec; 289(49):33878-86. PubMed ID: 25301942
[TBL] [Abstract][Full Text] [Related]
15. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
Dickinson SE; Rusche JJ; Bec SL; Horn DJ; Janda J; Rim SH; Smith CL; Bowden GT
Mol Carcinog; 2015 Nov; 54(11):1513-20. PubMed ID: 25307283
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells.
Hać A; Brokowska J; Rintz E; Bartkowski M; Węgrzyn G; Herman-Antosiewicz A
Eur J Nutr; 2020 Jun; 59(4):1421-1432. PubMed ID: 31123866
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of HDAC and HAT genes in atrophying skeletal muscle.
Beharry AW; Judge AR
Muscle Nerve; 2015 Dec; 52(6):1098-101. PubMed ID: 26372908
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells.
Lamparter CL; Winn LM
Toxicol Appl Pharmacol; 2016 Sep; 306():69-78. PubMed ID: 27381264
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells.
Cheng AC; Shen CJ; Hung CM; Hsu YC
J Med Food; 2019 May; 22(5):444-450. PubMed ID: 31084542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]